More than 16,000 Americans die each year from prescription drug overdoses. According to the Centers for Disease Control and Prevention, such deaths have increased more than 300 percent since 1998, while prescribing rates for these drugs quadrupled between 1999 and 2010. Narcotic pain relievers—known as opioids—were involved in 75 percent of the nation’s drug overdoses. Deaths connected to opioid misuse now exceed those from heroin and cocaine combined.
Prescription drug abuse also takes a financial toll, with public and private insurers incurring an estimated $72.5 billion in costs each year because of direct drug costs and medical care that results from the misuse and abuse of opioids and other drugs. In fact, every dollar spent on these prescriptions generates an estimated $41 in related medical claims. Yet health insurers—particularly Medicare and Medicaid—have limited options for curtailing drug overuse and abuse, and physicians and pharmacists have few reliable tools to detect at-risk patients.
The Pew Charitable Trusts recognizes prescription drug abuse as a public health crisis in the United States that must be addressed. Pew’s prescription drug abuse project works to develop and support policies that will help reduce the inappropriate use of prescription drugs while ensuring that patients with legitimate medical needs have access to effective pain management.
Public and private insurance plans use patient review and restriction (PRR) programs to encourage the safe use of opioids and other controlled substances. Through PRRs, insurers assign patients who are at risk for substance use disorder (SUD) to predesignated pharmacies and prescribers to obtain these drugs. Read More
Authorities today released Prince’s autopsy results, confirming that the renowned singer died from a prescription opioid overdose. Tragically, his cause of death is not rare: On April 21, Prince was just one of an estimated 52 Americans who lost their lives to an overdose of prescription pain relievers. Read More
On May 31, The Pew Charitable Trusts submitted a letter to the Substance Abuse and Mental Health Services Administration (SAMHSA), urging the agency to increase the cap for qualifying buprenorphine prescribers from 100 to 500 patients in order to expand access to medication-assisted treatment for opioid use disorder. Read More